Pluri Inc. Accrued Liabilities, Current
Pluri Inc. (PLUR) had Accrued Liabilities, Current of $928.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-09-10
- 2026-06-30: Accrued Liabilities, Current $928.00K.
- 2026-03-31: Accrued Liabilities, Current $700.00K.
- 2025-12-31: Accrued Liabilities, Current $566.00K.
- 2025-09-30: Accrued Liabilities, Current $884.00K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $928.00K 10-K · filed 2026-09-10 |
| 2026-03-31 | $700.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $566.00K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $884.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.18M 10-K · filed 2026-09-10 |
| 2025-03-31 | $1.58M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $841.00K 10-Q · filed 2025-02-11 |
| 2024-09-30 | $1.10M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.22M 10-K · filed 2025-09-17 |
| 2024-03-31 | $958.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.01M 10-Q · filed 2024-02-12 |
| 2023-09-30 | $1.02M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.21M 10-K · filed 2024-09-18 |
| 2023-03-31 | $1.33M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $1.51M 10-Q · filed 2023-02-13 |
| 2022-09-30 | $995.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.63M 10-K · filed 2023-09-12 |
| 2022-03-31 | $2.08M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $3.71M 10-Q · filed 2022-02-07 |
| 2021-09-30 | $5.26M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $5.94M 10-K · filed 2022-09-21 |
| 2021-03-31 | $4.79M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $3.74M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $3.52M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $3.02M 10-K · filed 2021-09-13 |
| 2020-03-31 | $2.60M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.55M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $2.38M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $3.74M 10-K · filed 2020-09-10 |
| 2019-03-31 | $3.34M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $2.94M 10-Q · filed 2019-02-06 |
| 2018-09-30 | $3.05M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $2.27M 10-K · filed 2019-09-12 |
| 2018-03-31 | $2.44M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $1.71M 10-Q · filed 2018-02-06 |
| 2017-09-30 | $1.49M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $1.47M 10-K · filed 2018-09-12 |
| 2017-03-31 | $1.43M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $1.08M 10-Q · filed 2017-02-08 |
| 2016-09-30 | $1.51M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $1.37M 10-K · filed 2017-09-07 |
| 2016-03-31 | $1.16M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.28M 10-Q · filed 2016-02-08 |
| 2015-09-30 | $1.01M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $910.00K 10-K · filed 2016-09-07 |
| 2015-03-31 | $661.00K 10-Q · filed 2015-05-06 |
| 2014-12-31 | $677.00K 10-Q · filed 2015-02-05 |
| 2014-09-30 | $1.00M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $915.00K 10-K · filed 2015-09-09 |
| 2014-03-31 | $1.16M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $902.00K 10-Q · filed 2014-02-05 |
| 2013-09-30 | $1.00M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $1.04M 10-K · filed 2014-09-11 |
| 2013-03-31 | $780.00K 10-Q · filed 2013-05-08 |
| 2012-12-31 | $426.00 10-Q · filed 2013-01-31 |
| 2012-09-30 | $1.07M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $922.00K 10-K · filed 2013-09-11 |
| 2012-03-31 | $230.00K 10-Q · filed 2012-05-08 |
| 2011-12-31 | $231.00K 10-Q · filed 2012-02-09 |
| 2011-09-30 | $376.00K 10-Q · filed 2011-11-09 |
| 2011-06-30 | $208.00K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |